US Stock MarketDetailed Quotes

ANIP ANI Pharmaceuticals

Watchlist
  • 56.830
  • +0.970+1.74%
Trading Nov 22 15:47 ET
1.19BMarket Cap-120914P/E (TTM)

ANI Pharmaceuticals Key Stats

ANI Pharmaceuticals Q3 2024 Earnings Date

Currency:USDNov 8, 2024

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
144.37M
148.33M
+3.96M
Beat Est.
+9.52%
+12.52%
+2.74%
EPS
-<0.01
-1.27
-1.27
Miss Est.
-100.71%
-382.22%
-39587.50%
Strong Buy

Oct 31, 2024

ANI Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 164.658M--
--2024/Q4-- / 175.118M--
Nov 8, 20242024/Q3148.332M / 144.375M--
Aug 6, 20242024/Q2138.040M / 129.053M--
May 10, 20242024/Q1137.430M / 126.028M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 164.658M--
--2024/Q4-- / 175.118M--
Nov 8, 20242024/Q3148.332M / 144.375M--
Aug 6, 20242024/Q2138.040M / 129.053M--
May 10, 20242024/Q1137.430M / 126.028M--

Unlock Free Earnings Estimates

ANI Pharmaceuticals Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Oct 31, 2024

Strong Buy

  • Buy

    75.00%
  • Hold

    25.00%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data